Alivus Life Sciences Limited
Glenmark Life Sciences, a subsidiary of Glenmark Pharmaceuticals Ltd, is one of the leading developers and manufacturers of select high-value Active Pharmaceutical Ingredients. The company further operates in Contract Development and manufacturing operations to offer services to specialty Pharmaceutical companies.
What Alivus files
- Investor Meet54
- Others29
- Updates18
- Important9
- Board Meeting8
- PPTs7
Alivus Life Sciences Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 08, 2026. Further, the company has submitted the Exchange a copy of Scrutinizers report along with voting results.
Alivus Life Sciences Limited has informed the Exchange about Copy of Newspaper Publication of Notice of 15th Annual General Meeting and e-voting information.
Alivus Life Sciences Limited has informed the Exchange regarding Notice of Annual General Meeting (AGM) to be held on September 8, 2026. Enclosed please find herewith Notice of the 15th AGM.
Alivus Life Sciences Limited has informed the Exchange about Copy of Newspaper Publication regarding intimation of 15th AGM.
Alivus Life Sciences Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 08, 2026